Modest Money Contributor
The author of this article is a contributor to Modest Money.
Modest Money Contributor's Latest Posts
Attis Industries (ATIS) Stock: An Investment Worth Your Consideration
Today’s market is one that is ripe with disruption. As innovation leads the charge and technology drives further advancements in how we do just about everything, a new breed of investment opportunity is being born. That’s where we get to Attis Industries (NASDAQ: ATIS). Attis Industries is a company that is driven by innovation to solve challenges in […]
Med-X: Why Investors Should Be Paying Attention
The world is changing, and so too are opinions. Today, opinions with regard to cannabis, pharmaceuticals, chemicals, and more are constantly being scrutinized. Med-X is a company that is riding on the leading edge of this change and creating a compelling opportunity in the process. What Is Med-X Med-X is a company that is becoming a disruptive force across multiple […]
Trovagene (TROV) Stock: Providing New Cancer Treatment Options With Onvansertib
We all know what cancer is. The debilitating, often life-threatening condition can be incredibly difficult to treat. As a result, new therapies are being developed in an effort to bring improved treatment options to patients, especially for some of the toughest-to-treat cancers. That’s where Trovagene (Nasdaq: TROV) comes in with their drug candidate, Onvansertib. Trovagene caught my attention […]
Share Price Rises As Groupon (GRPN) Takes To The Big Screen
Only last month, Groupon suffered its worst single day slide on the NASDAQ since May 21, 2007, when shares slid by 10.6% on Wednesday, November 7. The third quarter results for the company were also less than positive with profits of $593 million compared to the analysts projections of $602 million. At the time, there […]
Why SiriusXM Stock Is A Stock To Hold Long Term
When the concept of satellite radio came about, many people scoffed at the idea. Why pay for something you get 100% for free? I was one of these people. Why would I spend my money on a subscription to SiriusXM (NASDAQ: SIRI)? Well, one day I decided to take the plunge, just to see what it […]
Nio Is Off To A Hot Start: Here Is Why You Should Avoid It
Nio is a new public offering for investors and so far, the stock has had a wild ride. Just like with Sonos, which I wrote about recently, Nio looks great from afar, but once you start digging into this company, you see red flags everywhere. Still, many investors will ignore these red flags because they see […]
3 Small-Cap Stocks With 5%+ Dividend Yields
The Russell 2000 Index holds approximately 2,000 small-cap stocks. The Russell 2000 Index focuses on the smallest companies in the Russell 3000 Index, and therefore the Russell 2000 Index is viewed as a benchmark for small-cap stocks. Small-cap stocks often do not pay dividends to shareholders, and if they do, usually have low dividend yields. Small companies need to […]
Summit Semiconductor (WISA) Stock: A Household Name In The Making
Technology has brought plenty of revolutionary changes to how we see entertainment and communication. Think about Bluetooth, Wi-Fi, and Blu-ray. All of these technologies have become household names after providing solutions to key problems with entertainment in communication. That’s exactly what Summit Semiconductor, Inc. (NASDAQ: WISA) aims to do with WiSA, and in my opinion, they’re well on […]
Naked Brand Group (NAKD) Stock: Consolidation Never Sounded So Good
Once dominated by a handful of players, the lingerie and swimwear industry, which has been distributed by upstart brands, has become highly fragmented. However, if Naked Brand Group (NAKD) has anything to do with it, that’s going to change. After the Bendon Acquisition that happened earlier this year, NAKD is likely to take the market […]
The Phases Of Clinical Stage Biotechnology Companies
If you’re considering investing in clinical stage biotechnology companies, it’s important that you know the phases to watch for. After all, as the companies step into each new phase, the move tends to act as a catalyst, sending the value of the stock flying dramatically toward the top. So, where are these catalysts in clinical stage biotechnology […]
HyreCar Inc. (HYRE) Stock: Selling Shovels In A Gold Rush
When I say names like Uber and Lyft, chances are that not only do you know these names, but they elicit a sort of emotional response. After all, when we see or hear things that we’re familiar with, we tend to get excited, and Uber and Lyft are the pioneers that changed the way we […]
